1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Glucagon
Trade Name:
Baqsimi
Manufacturer/Distributor:
Eli Lilly Canada
Classification:
Hyperglycemic agent
ATC Class:
H04AA01 - glucagon
Status:
active
Notice of Compliance (yyyy/mm/dd):
2019/09/25
Date Marketed in Canada (yyyy/mm/dd):
2019/11/20
Presentation:
Powder for nasal administration: 3 mg. DIN: 02492415
Comments:
For the treatment of severe hypoglycemic reactions which may occur in the management of insulin treated patients with diabetes mellitus, when impaired consciousness precludes oral carbohydrates.
Back to:
Drug Product Listings 
